Gamma secretase-mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 16680150.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mice transgenic for antisense Notch and normal mice treated with inhibitors of the Notch-activating enzyme gamma-secretase showed reduced damage to brain cells and improved functional outcome in a model of focal ischemic stroke. Notch endangers neurons by modulating pathways that increase their vulnerability to apoptosis, and by activating microglial cells and stimulating the infiltration of proinflammatory leukocytes. These findings suggest that Notch signaling may be a therapeutic target for treatment of stroke and related neurodegenerative conditions.
Medical subject headings
- Brain
- Brain Ischemia
- Endopeptidases
- Receptor, Notch1
- Signal Transduction
- Stroke